TY  - RPRT
TI  - A bispecific antibody overcomes limitations of prior strategies to achieve effective and tumor-selective Death Receptor 5 (DR5) clustering
AU  - Goldmacher, V. S.
AU  - Gershteyn, I. M.
AU  - Chari, R.
AU  - Kovtun, Y.
PY  - 2025
DO  - 10.1101/2025.01.10.632444
UR  - https://www.biorxiv.org/content/10.1101/2025.01.10.632444v1
ID  - 10.1101/2025.01.10.632444
ER  -